Italy: drug-related information and data
Our partner in Italy
Presidency of the Council of Ministers - Drug Policy Department
Via dei Laterani, 34
I – 00184 Roma
Tel. +39 0667796350
Fax +39 0667796843
Head of focal point: Mrs Elisabetta Simeoni
Contact person: Mrs Silvia ZanoneBy means of a decree of the President of the Council of Ministers of 20 June 2008, the Drug Policy Department was set up at the Presidency of the Council of Ministers and placed under the functional responsibility of the Prime Ministerial Under-secretary with delegated responsibility for drugs.
The work of the structure is to promote, guide and coordinate the Government’s initiatives aimed at combating the spread of drug and alcohol dependency as well as to promote cooperation with the competent public administrations in the sector, associations, therapeutic communities and welcome centres. Within the Department is located the Italian Observatory on drugs and drug addiction, which is responsible for the collection, processing and interpretation of data and information of a statistical-epidemiological, pharmacological-clinical, and psychosocial nature and for documentation on the use, abuse, dealing and trafficking of drugs and psychotropic substances. The Department is also responsible for dealing with EU and international bodies operating in the sector. The Reitox Focal Point is an integral part of the Department’s technical and scientific division.
E-mail addresses have been inserted in a way discouraging spam. Please replace [a] by @ before actually using any of the e-mail addresses.
Legal profiles describe national drug-related legislation in a standardised, comparable format. Topics covered include possession, trafficking, classification, prosecution, prevention, treatment, among others.
Each treatment profile provides information on the national context, treatment registries and monitoring systems, treatment demand, availability of treatment services as well as references and resources.
Each overview describes: the national context; references and resources; key responses for preventing and reducing drug-related infectious diseases and; drug-related deaths and drug-related harms in recreational settings.
These data sheets on drug-related public expenditure cover 30 countries and examine how much countries spend on drug-related activities, whether there are specific budgets allocated to drug policy documents, and how drug-related expenditure has evolved over time.